Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses

Several recent phase 3 clinical trials of attention-deficit/hyperactivity disorder (ADHD) medications have used the Weiss Functional Impairment Rating Scale-Parent Report (WFIRS-P). Here, we assess WFIRS-P response in individual patients in two pivotal trials of lisdexamfetamine dimesylate (LDX) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Coghill, David R., Werner-Kiechle, Tamara, Farahbakhshian, Sepehr, Bliss, Caleb, Robertson, Brigitte, Huss, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060241/
https://www.ncbi.nlm.nih.gov/pubmed/32691164
http://dx.doi.org/10.1007/s00787-020-01586-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060241/
https://www.ncbi.nlm.nih.gov/pubmed/32691164
http://dx.doi.org/10.1007/s00787-020-01586-5

Ejemplares similares